Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

ClinicalTrials.gov ID: NCT01457677

Public ClinicalTrials.gov record NCT01457677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)

Study identification

NCT ID
NCT01457677
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
357 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • RO4995819 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
May 31, 2014
Completion
May 31, 2014
Last update posted
Nov 1, 2016

2011 – 2014

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Not listed Phoenix Arizona 85381
Not listed Oakland California 94607
Not listed Redlands California 92374
Not listed San Diego California 92103
Not listed Stanford California 94305
Not listed Torrance California 90502
Not listed Victorville California 92295
Not listed Denver Colorado 80239
Not listed Coral Springs Florida 33067
Not listed Gainsville Florida 32607
Not listed Jacksonville Florida 32216
Not listed Lauderhill Florida 33319
Not listed North Miami Florida 33161
Not listed Ocala Florida 34471
Not listed Atlanta Georgia 30308
Not listed Roswell Georgia 30076
Not listed Smyrna Georgia 30080
Not listed Chicago Illinois 60612-3244
Not listed Prairie Village Kansas 66206
Not listed Wichita Kansas 67214
Not listed Baltimore Maryland 21208
Not listed Boston Massachusetts 02114
Not listed Watertown Massachusetts 02472
Not listed Flowood Mississippi 39232
Not listed O'Fallon Missouri 63368
Not listed Albuquerque New Mexico 87131
Not listed New York New York 10021
Not listed New York New York 10029
Not listed New York New York 10032
Not listed Rochester New York 14618
Not listed Durham North Carolina 27710
Not listed Beachwood Ohio 44122
Not listed Canton Ohio 44718
Not listed Cincinnati Ohio 45215
Not listed Cincinnati Ohio 45227
Not listed Jenkintown Pennsylvania 19046
Not listed Media Pennsylvania 19063
Not listed Columbia South Carolina 29201
Not listed Arlington Texas 76012
Not listed Houston Texas 77030
Not listed Salt Lake City Utah 84106
Not listed Richmond Virginia 23298
Not listed Roanoke Virginia 24014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01457677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01457677 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →